Event : FDA Clinical Trial Auditing and the due diligence Companies should conduct as part of their monitoring program - Webinar By GCP http://www.rsc.org/events/detail/5678/FDA%20Clinical%20Trial%20Auditing%20and%20the%20due%20diligence%20Companies%20should%20conduct%20as%20part%20of%20their%20monitoring%20program%20-%20Webinar%20By%20GCP This is a feed for event : FDA Clinical Trial Auditing and the due diligence Companies should conduct as part of their monitoring program - Webinar By GCP Thu, 11 Sep 2014 13:13:13 +0100 5678 5678 http://www.rsc.org/events/detail/5678/FDA%20Clinical%20Trial%20Auditing%20and%20the%20due%20diligence%20Companies%20should%20conduct%20as%20part%20of%20their%20monitoring%20program%20-%20Webinar%20By%20GCP FDA Clinical Trial Auditing and the due diligence Companies should conduct as part of their monitoring program - Webinar By GCP Event dates: 10 May 2011<br/>Event summary: Overview: The main principle is to follow exactly the signed and approved (IRB + PI) Protocol to the letter. This, in fact, is included on the FDA Form 1572. In the current regulatory climate, GC<br/>Event Venue: Online Training Webinar, Wilmington, 19801, United States Thu, 11 Sep 2014 13:13:13 +0100 2014-09-11T13:13:13+01:00